Jon Lømo

  • Group leader
 

Publications 2024

Andresen NK, Røssevold AH, Borgen E, Schirmer CB, Gilje B, Garred Ø, Lømo J, Stensland M, Nordgård O, Falk RS, Mathiesen RR, Russnes HG, Kyte JA, Naume B (2024)
Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors - a biomarker analysis of the ALICE and ICON trials
Mol Oncol (in press)
DOI 10.1002/1878-0261.13675, PubMed 38978352

Ohnstad HO, Blix ES, Akslen LA, Gilje B, Raj SX, Skjerven H, Borgen E, Janssen EAM, Mortensen E, Brekke MB, Falk RS, Schlichting E, Boge B, Songe-Møller S, Olsson P, Heie A, Mannsåker B, Vestlid MA, Kursetgjerde T, Gravdehaug B, Suhrke P, Sanchez E, Bublevic J, Røe OD, Geitvik GA et al. (2024)
Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer-a prospective national multicentre study (EMIT-1)
ESMO Open, 9 (6), 103475
DOI 10.1016/j.esmoop.2024.103475, PubMed 38838499

Publications 2022

Brunvoll SH, Flote VG, Halset EH, Bertheussen GF, Skjerven H, Lømo J, Thune I, Hjartåker A (2022)
Normal and unusual days for dietary intake during the 12 months after a breast cancer diagnosis in women
Eur J Nutr, 61 (8), 3873-3885
DOI 10.1007/s00394-022-02925-9, PubMed 35750881

Røssevold AH, Andresen NK, Bjerre CA, Gilje B, Jakobsen EH, Raj SX, Falk RS, Russnes HG, Jahr T, Mathiesen RR, Lømo J, Garred Ø, Chauhan SK, Lereim RR, Dunn C, Naume B, Kyte JA (2022)
Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial
Nat Med, 28 (12), 2573-2583
DOI 10.1038/s41591-022-02126-1, PubMed 36482103

Publications 2021

Talwelkar SS, Mäyränpää MI, Søraas L, Potdar S, Bao J, Hemmes A, Linnavirta N, Lømo J, Räsänen J, Knuuttila A, Wennerberg K, Verschuren EW (2021)
Functional diagnostics using fresh uncultured lung tumor cells to guide personalized treatments
Cell Rep Med, 2 (8), 100373
DOI 10.1016/j.xcrm.2021.100373, PubMed 34467250

Publications 2020

Brunvoll SH, Thune I, Bertheussen GF, Fjeldheim F, Flote VG, Frydenberg H, Lundgren S, Skjerven H, Lømo J, Fagerland MW, McTiernan A, Schlichting E, Hjartåker A (2020)
Dietary changes in early-stage breast cancer patients from pre-surgery and over the 12 months post-surgery
Br J Nutr, 125 (2), 172-182
DOI 10.1017/S0007114520002627, PubMed 32811572

Sondén ECB, Sebuødegård S, Korvald C, Lømo J, Schlichting E, Brandal SHB, Hofvind S (2020)
[Cosmetic breast implants and breast cancer]
Tidsskr Nor Laegeforen, 140 (3)
DOI 10.4045/tidsskr.19.0266, PubMed 32105043

Sondén ECB, Sebuødegård S, Korvald C, Lømo J, Schlichting E, Brandal SHB, Hofvind S (2020)
[Correction: Cosmetic breast implants and breast cancer]
Tidsskr Nor Laegeforen, 140 (4)
DOI 10.4045/tidsskr.20.0163, PubMed 32192257

Publications 2019

Panagopoulos I, Gorunova L, Andersen HK, Pedersen TD, Lømo J, Lund-Iversen M, Micci F, Heim S (2019)
Genetic Characterization of Myoid Hamartoma of the Breast
Cancer Genomics Proteomics, 16 (6), 563-568
DOI 10.21873/cgp.20158, PubMed 31659109

Publications 2018

Hofvind S, Hovda T, Holen ÅS, Lee CI, Albertsen J, Bjørndal H, Brandal SHB, Gullien R, Lømo J, Park D, Romundstad L, Suhrke P, Vigeland E, Skaane P (2018)
Digital Breast Tomosynthesis and Synthetic 2D Mammography versus Digital Mammography: Evaluation in a Population-based Screening Program
Radiology, 287 (3), 787-794
DOI 10.1148/radiol.2018171361, PubMed 29494322

Madssen TS, Thune I, Flote VG, Lundgren S, Bertheussen GF, Frydenberg H, Wist E, Schlichting E, Schäfer H, Fjøsne HE, Vettukattil R, Lømo J, Bathen TF, Giskeødegård GF (2018)
Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment
Br J Cancer, 119 (9), 1144-1154
DOI 10.1038/s41416-018-0211-x, PubMed 30401977

Samardzic T, Lømo J, Skaane P (2018)
Screening-detected desmoid tumor of the breast: findings at conventional imaging and digital breast tomosynthesis
Acta Radiol Open, 7 (1), 2058460117752034
DOI 10.1177/2058460117752034, PubMed 29375894

Publications 2017

Vaysse C, Lomo J, Garred O, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, Frydenberg H, Husoy A, Lundgren S, Fagerland MW, Richardsen E, Wist EA, Muller C, Thune I (2017)
Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer (vol 3, 35, 2017)
npj Breast Cancer, 3, 35
DOI 10.1038/s41523-017-0030-x

Vaysse C, Lømo J, Garred Ø, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, Frydenberg H, Husøy A, Lundgren S, Fagerland MW, Richardsen E, Wist EA, Muller C, Thune I (2017)
Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer
NPJ Breast Cancer, 3, 19
DOI 10.1038/s41523-017-0015-9, PubMed 28649659

Vaysse C, Lømo J, Garred Ø, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, Frydenberg H, Husøy A, Lundgren S, Fagerland MW, Richardsen E, Wist EA, Muller C, Thune I (2017)
Erratum: Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer
NPJ Breast Cancer, 3, 35
DOI 10.1038/s41523-017-0030-x, PubMed 28884144

Publications 2016

Flote VG, Vettukattil R, Bathen TF, Egeland T, McTiernan A, Frydenberg H, Husøy A, Finstad SE, Lømo J, Garred Ø, Schlichting E, Wist EA, Thune I (2016)
Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer
Lipids Health Dis, 15, 56
DOI 10.1186/s12944-016-0225-4, PubMed 26970778

Publications 2014

Chen Y, Klingen TA, Wik E, Aas H, Vigeland E, Liestøl K, Garred Ø, Mæhlen J, Akslen LA, Lømo J (2014)
Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based study
Diagn Pathol, 9, 230
DOI 10.1186/s13000-014-0230-8, PubMed 25522915

Eide NA, Baerland TP, Sauesund E, Lømo J, Lund-Iversen M, Liestøl S (2014)
Relapse of acute lymphoblastic leukaemia (ALL)
Acta Ophthalmol, 93 (5), e395-e396
DOI 10.1111/aos.12619, PubMed 25495443

Publications 2011

Aden P, Paulsen RE, Mæhlen J, Løberg EM, Goverud IL, Liestøl K, Lømo J (2011)
Glucocorticoids dexamethasone and hydrocortisone inhibit proliferation and accelerate maturation of chicken cerebellar granule neurons
Brain Res, 1418, 32-41
DOI 10.1016/j.brainres.2011.08.053, PubMed 21925649

Publications 2010

Strøm BO, Aden P, Mathisen GH, Lømo J, Davanger S, Paulsen RE (2010)
Transfection of chicken cerebellar granule neurons used to study glucocorticoid receptor regulation by nuclear receptor 4A (NR4A)
J Neurosci Methods, 193 (1), 39-46
DOI 10.1016/j.jneumeth.2010.08.012, PubMed 20727911

Publications 2008

Aden P, Goverud I, Liestøl K, Løberg EM, Paulsen RE, Maehlen J, Lømo J (2008)
Low-potency glucocorticoid hydrocortisone has similar neurotoxic effects as high-potency glucocorticoid dexamethasone on neurons in the immature chicken cerebellum
Brain Res, 1236, 39-48
DOI 10.1016/j.brainres.2008.07.095, PubMed 18706896

Publications 2006

Jacobs CM, Aden P, Mathisen GH, Khuong E, Gaarder M, Løberg EM, Lømo J, Maehlen J, Paulsen RE (2006)
Chicken cerebellar granule neurons rapidly develop excitotoxicity in culture
J Neurosci Methods, 156 (1-2), 129-35
DOI 10.1016/j.jneumeth.2006.02.012, PubMed 16564575

Jacobs CM, Trinh MD, Rootwelt T, Lømo J, Paulsen RE (2006)
Dexamethasone induces cell death which may be blocked by NMDA receptor antagonists but is insensitive to Mg2+ in cerebellar granule neurons
Brain Res, 1070 (1), 116-23
DOI 10.1016/j.brainres.2005.10.093, PubMed 16403471

Sauer T, Garred O, Lømo J, Naess O (2006)
Assessing invasion criteria in fine needle aspirates from breast carcinoma diagnosed as DICS or invasive carcinoma: can we identify an invasive component in addition to DCIS?
Acta Cytol, 50 (3), 263-70
DOI 10.1159/000325952, PubMed 16780019

Publications 2005

Munkeby BH, Børke WB, Bjørnland K, Sikkeland LI, Borge GI, Lømo J, Rivera S, Khrestchatisky M, Halvorsen B, Saugstad OD (2005)
Resuscitation of hypoxic piglets with 100% O2 increases pulmonary metalloproteinases and IL-8
Pediatr Res, 58 (3), 542-8
DOI 10.1203/01.PDR.0000179407.46810.2D, PubMed 16148071

Sauer T, Lømo J, Garred O, Naess O (2005)
Cytologic features of ductal carcinoma in situ in fine-needle aspiration of the breast mirror the histopathologic growth pattern heterogeneity and grading
Cancer, 105 (1), 21-7
DOI 10.1002/cncr.20735, PubMed 15593325

Publications 2003

Sauer T, Myrvold K, Lømo J, Anderssen KY, Skaane P (2003)
Fine-needle aspiration cytology in nonpalpable mammographic abnormalities in breast cancer screening: results from the breast cancer screening programme in Oslo 1996-2001
Breast, 12 (5), 314-9
DOI 10.1016/s0960-9776(03)00102-4, PubMed 14659146

Publications 2001

Siem G, Natvig K, Kolbenstvedt A, Lømo J (2001)
[Salivary gland drainage into the thyroglossal duct]
Tidsskr Nor Laegeforen, 121 (2), 166-7
PubMed 11475191

Publications 2000

Josefsen D, Myklebust JH, Lømo J, Sioud M, Blomhoff HK, Smeland EB (2000)
Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells
Stem Cells, 18 (4), 261-72
DOI 10.1634/stemcells.18-4-261, PubMed 10924092

Løberg EM, Lømo J, Maehlen J (2000)
[Will the revolutionary knowledge of apoptosis play an important role in medicine?]
Lakartidningen, 97 (12), 1389-93
PubMed 10765620

Løberg EM, Lømo J, Maehlen J (2000)
[Will the revolutionary knowledge of apoptosis play an important role in medicine?]
Tidsskr Nor Laegeforen, 120 (1), 57-61
PubMed 10815481

Publications 1999

Josefsen D, Blomhoff HK, Lømo J, Blystad AK, Smeland EB (1999)
Retinoic acid induces apoptosis of human CD34+ hematopoietic progenitor cells: involvement of retinoic acid receptors and retinoid X receptors depends on lineage commitment of the hematopoietic progenitor cells
Exp Hematol, 27 (4), 642-53
DOI 10.1016/s0301-472x(98)00073-3, PubMed 10210322

Publications 1998

Finstad HS, Myhrstad MC, Heimli H, Lømo J, Blomhoff HK, Kolset SO, Drevon CA (1998)
Multiplication and death-type of leukemia cell lines exposed to very long-chain polyunsaturated fatty acids
Leukemia, 12 (6), 921-9
DOI 10.1038/sj.leu.2401030, PubMed 9639421

Lømo J (1998)
[Apoptosis--new possibilities in the treatment of cancer]
Tidsskr Nor Laegeforen, 118 (22), 3436-41
PubMed 9800494

Lømo J, Smeland EB, Ulven S, Natarajan V, Blomhoff R, Gandhi U, Dawson MI, Blomhoff HK (1998)
RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes
J Cell Physiol, 175 (1), 68-77
DOI 10.1002/(SICI)1097-4652(199804)175:1<68::AID-JCP8>3.0.CO;2-A, PubMed 9491782

Vivas S, Palacio MA, Lomo J, Cadenas F, Linares A, Rodríguez M, Rodrigo L (1998)
[Arterioportal fistula and hemobilia in a patient with hepatic transplant]
Gastroenterol Hepatol, 21 (2), 88-9
PubMed 9549185

Vivas S, Palacio MA, Rodríguez M, Lomo J, Cadenas F, Giganto F, Rodrigo L (1998)
Ambulatory liver biopsy: complications and evolution in 264 cases
Rev Esp Enferm Dig, 90 (3), 175-82
PubMed 9595938

Publications 1997

Hallan E, Blomhoff HK, Smeland EB, Lømo J (1997)
Involvement of ICE (Caspase) family in gamma-radiation-induced apoptosis of normal B lymphocytes
Scand J Immunol, 46 (6), 601-8
DOI 10.1046/j.1365-3083.1997.d01-173.x, PubMed 9420624

Lømo J, Blomhoff HK, Jacobsen SE, Krajewski S, Reed JC, Smeland EB (1997)
Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl-xL and Mcl-1
Blood, 89 (12), 4415-24
PubMed 9192766

Vivas S, Rodríguez M, Palacio MA, Cadenas F, Lomo J, Rodrigo L (1997)
[Acute hepatitis associated with terbinafine]
Gastroenterol Hepatol, 20 (9), 456-8
PubMed 9445740

Publications 1996

Lømo J (1996)
The regulation of apoptosis in resting human B lymphocytes
Department of Immunology, Institute for Cancer Research, The Norwegian Radium Hospital and The Norwegian Cancer Society, Oslo, 1 b. (flere pag.)
BIBSYS 971297177, ISBN 82-7633-089-4

Lømo J, Smeland EB, Krajewski S, Reed JC, Blomhoff HK (1996)
Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes
Cancer Res, 56 (1), 40-3
PubMed 8548771

Publications 1995

FAHLMAN C, JACOBSEN SE, SMELAND EB, LOMO J, NAESS CE, FUNDERUD S, BLOMHOFF HK (1995)
ALL-TRANS-RETINOIC AND 9-CIS-RETINOIC ACID INHIBIT GROWTH OF NORMAL HUMAN AND MURINE B-CELL PRECURSORS
J. Immunol., 155 (1), 58-65

Fahlman C, Jacobsen SE, Smeland EB, Lømo J, Naess CE, Funderud S, Blomhoff HK (1995)
All-trans- and 9-cis-retinoic acid inhibit growth of normal human and murine B cell precursors
J Immunol, 155 (1), 58-65
PubMed 7602122

Lømo J, Blomhoff HK, Beiske K, Stokke T, Smeland EB (1995)
TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes
J Immunol, 154 (4), 1634-43
PubMed 7836748

Publications 1991

Lømo J, Smeland EB, Stokke T, Holte H, Funderud S, Blomhoff HK (1991)
Differential effects of interferon-gamma and low molecular weight BCGF on growth of human B lymphocytes; interferon-gamma prolongs the increased c-MYC mRNA levels after activation
Scand J Immunol, 33 (4), 365-73
DOI 10.1111/j.1365-3083.1991.tb01783.x, PubMed 1902001

Publications 1987

Lømo J, Holte H, de Lange Davies C, Ruud E, Laukas M, Smeland EB, Godal T, Blomhoff HK (1987)
Downregulation of c-myc RNA is not a prerequisite for reduced cell proliferation, but is associated with G1 arrest in B-lymphoid cell lines
Exp Cell Res, 172 (1), 84-91
DOI 10.1016/0014-4827(87)90095-4, PubMed 3115797

Page visits: 4268